Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S.
Travaglino F, et al. Among authors: di somma s.
Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.
Am J Emerg Med. 2014.
PMID: 24559907